더보기Eli Lilly’s oral GLP-1 Foundayo enters the market at a fraction of Mounjaro’s price. Discover whether this pill expands the obesity market or risks cannibalizing premium injections. Eli Lilly’s newly approved oral GLP-1, Foundayo (orforglipron), enters the obesity market with a substantial pricing discount—costing roughly £100 to £120 a month in the UK compared to approximately £330 for ..
